219 related articles for article (PubMed ID: 30640794)
1. Cotreatment with sorafenib and oleanolic acid induces reactive oxygen species-dependent and mitochondrial-mediated apoptotic cell death in hepatocellular carcinoma cells.
Liese J; Hinrichs TM; Lange M; Fulda S
Anticancer Drugs; 2019 Mar; 30(3):209-217. PubMed ID: 30640794
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel oxidative stress induced cell death by Sorafenib and oleanolic acid in human hepatocellular carcinoma cells.
Lange M; Abhari BA; Hinrichs TM; Fulda S; Liese J
Biochem Pharmacol; 2016 Oct; 118():9-17. PubMed ID: 27544320
[TBL] [Abstract][Full Text] [Related]
3. Smac mimetic and oleanolic acid synergize to induce cell death in human hepatocellular carcinoma cells.
Liese J; Abhari BA; Fulda S
Cancer Lett; 2015 Aug; 365(1):47-56. PubMed ID: 25917078
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib induces mitochondrial dysfunction and exhibits synergistic effect with cysteine depletion by promoting HCC cells ferroptosis.
Li Y; Xia J; Shao F; Zhou Y; Yu J; Wu H; Du J; Ren X
Biochem Biophys Res Commun; 2021 Jan; 534():877-884. PubMed ID: 33162029
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
[TBL] [Abstract][Full Text] [Related]
6. A piperazidine derivative of 23-hydroxy betulinic acid induces a mitochondria-derived ROS burst to trigger apoptotic cell death in hepatocellular carcinoma cells.
Yao N; Li YJ; Lei YH; Hu N; Chen WM; Yao Z; Yu M; Liu JS; Ye WC; Zhang DM
J Exp Clin Cancer Res; 2016 Dec; 35(1):192. PubMed ID: 27931237
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells.
Li J; Wu DD; Zhang JX; Wang J; Ma JJ; Hu X; Dong WG
World J Gastroenterol; 2018 May; 24(17):1901-1910. PubMed ID: 29740205
[TBL] [Abstract][Full Text] [Related]
8. NG, a novel PABA/NO-based oleanolic acid derivative, induces human hepatoma cell apoptosis via a ROS/MAPK-dependent mitochondrial pathway.
Liu L; Fu J; Li T; Cui R; Ling J; Yu X; Ji H; Zhang Y
Eur J Pharmacol; 2012 Sep; 691(1-3):61-8. PubMed ID: 22824464
[TBL] [Abstract][Full Text] [Related]
9. 16-O-caffeoyl-16-hydroxylhexadecanoic acid, a medicinal plant-derived phenylpropanoid, induces apoptosis in human hepatocarcinoma cells through ROS-dependent endoplasmic reticulum stress.
Huang RZ; Huang XC; Zhang B; Jia HY; Liao ZX; Wang HS
Phytomedicine; 2018 Mar; 41():33-44. PubMed ID: 29519317
[TBL] [Abstract][Full Text] [Related]
10. Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway.
Liu J; Wei X; Wu Y; Wang Y; Qiu Y; Shi J; Zhou H; Lu Z; Shao M; Yu L; Tong L
Cell Oncol (Dordr); 2016 Aug; 39(4):333-42. PubMed ID: 27016209
[TBL] [Abstract][Full Text] [Related]
11. Sorafenib induces preferential apoptotic killing of a drug- and radio-resistant Hep G2 cells through a mitochondria-dependent oxidative stress mechanism.
Chiou JF; Tai CJ; Wang YH; Liu TZ; Jen YM; Shiau CY
Cancer Biol Ther; 2009 Oct; 8(20):1904-13. PubMed ID: 19770576
[TBL] [Abstract][Full Text] [Related]
12. JNK activation and translocation to mitochondria mediates mitochondrial dysfunction and cell death induced by VDAC opening and sorafenib in hepatocarcinoma cells.
Heslop KA; Rovini A; Hunt EG; Fang D; Morris ME; Christie CF; Gooz MB; DeHart DN; Dang Y; Lemasters JJ; Maldonado EN
Biochem Pharmacol; 2020 Jan; 171():113728. PubMed ID: 31759978
[TBL] [Abstract][Full Text] [Related]
13. Application of self-assembly peptides targeting the mitochondria as a novel treatment for sorafenib-resistant hepatocellular carcinoma cells.
Hong TH; Jeena MT; Kim OH; Kim KH; Choi HJ; Lee KH; Hong HE; Ryu JH; Kim SJ
Sci Rep; 2021 Jan; 11(1):874. PubMed ID: 33441650
[TBL] [Abstract][Full Text] [Related]
14. The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells.
Louandre C; Marcq I; Bouhlal H; Lachaier E; Godin C; Saidak Z; François C; Chatelain D; Debuysscher V; Barbare JC; Chauffert B; Galmiche A
Cancer Lett; 2015 Jan; 356(2 Pt B):971-7. PubMed ID: 25444922
[TBL] [Abstract][Full Text] [Related]
15. Carnosic acid induces apoptosis of hepatocellular carcinoma cells via ROS-mediated mitochondrial pathway.
Zhang X; Chen Y; Cai G; Li X; Wang D
Chem Biol Interact; 2017 Nov; 277():91-100. PubMed ID: 28918123
[TBL] [Abstract][Full Text] [Related]
16. GL-V9 induced upregulation and mitochondrial localization of NAG-1 associates with ROS generation and cell death in hepatocellular carcinoma cells.
Zhang X; Kang Y; Huo T; Tao R; Wang X; Li Z; Guo Q; Zhao L
Free Radic Biol Med; 2017 Nov; 112():49-59. PubMed ID: 28697922
[TBL] [Abstract][Full Text] [Related]
17. Synergy with interferon-lambda 3 and sorafenib suppresses hepatocellular carcinoma proliferation.
Yan Y; Wang L; He J; Liu P; Lv X; Zhang Y; Xu X; Zhang L; Zhang Y
Biomed Pharmacother; 2017 Apr; 88():395-402. PubMed ID: 28122304
[TBL] [Abstract][Full Text] [Related]
18. III-10, a newly synthesized flavonoid, induces cell apoptosis with the involvement of reactive oxygen species-mitochondria pathway in human hepatocellular carcinoma cells.
Dai Q; Yin Q; Zhao Y; Guo R; Li Z; Ma S; Lu N
Eur J Pharmacol; 2015 Oct; 764():353-362. PubMed ID: 26164795
[TBL] [Abstract][Full Text] [Related]
19. Oleanolic acid arrests cell cycle and induces apoptosis via ROS-mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreatic cancer cells.
Wei J; Liu M; Liu H; Wang H; Wang F; Zhang Y; Han L; Lin X
J Appl Toxicol; 2013 Aug; 33(8):756-65. PubMed ID: 22678527
[TBL] [Abstract][Full Text] [Related]
20. MSFTZ, a flavanone derivative, induces human hepatoma cell apoptosis via a reactive oxygen species- and caspase-dependent mitochondrial pathway.
Ying M; Tu C; Ying H; Hu Y; He Q; Yang B
J Pharmacol Exp Ther; 2008 Jun; 325(3):758-65. PubMed ID: 18323457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
